Fig. 10From: Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine modelSchematic representation of the different steps used for Targeted Doxorubicin liposomes formulationBack to article page